Tumor histopathology predicts outcomes after resection of colorectal cancer liver metastases treated with and without pre-operative chemotherapy.

about

Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy

P2860

Q56524446-604CBE3D-AA11-4DB9-B843-2DBEFF3DE02C

P2860

Tumor histopathology predicts outcomes after resection of colorectal cancer liver metastases treated with and without pre-operative chemotherapy.

Item

http://www.wikidata.org/entity/Q45032127

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Tumor histopathology predicts ...... ut pre-operative chemotherapy.

@en

Tumor histopathology predicts ...... ut pre-operative chemotherapy.

@nl

type

Item

label

Tumor histopathology predicts ...... ut pre-operative chemotherapy.

@en

Tumor histopathology predicts ...... ut pre-operative chemotherapy.

@nl

prefLabel

Tumor histopathology predicts ...... ut pre-operative chemotherapy.

@en

Tumor histopathology predicts ...... ut pre-operative chemotherapy.

@nl

P1476

Tumor histopathology predicts ...... ut pre-operative chemotherapy.

@en

P2093

Joseph W Leach

http://www.w3.org/2001/XMLSchema#string

Lawrence J Burgart

http://www.w3.org/2001/XMLSchema#string

Mark J Hill

http://www.w3.org/2001/XMLSchema#string

Robin J Parker

http://www.w3.org/2001/XMLSchema#string

Srinevas K Reddy

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; An international multi-center data analysis using LiverMetSurvey.

A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases.

Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.

Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab.

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

Multicenter validation study of pathologic response and tumor thickness at the tumor-normal liver interface as independent predictors of disease-free survival after preoperative chemotherapy and surgery for colorectal liver metastases.

Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor.

Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.

P304

456-462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.24144

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27100028

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

Tumor histopathology predicts outcomes after resection of colorectal cancer liver metastases treated with and without pre-operative chemotherapy.

about

P2860

P2860

Tumor histopathology predicts outcomes after resection of colorectal cancer liver metastases treated with and without pre-operative chemotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921